Roivant Sciences Ltd
(NAS:ROIVW)
$
2.75
-0.11 (-3.85%)
Market Cap: 0
Enterprise Value: 0
PE Ratio: 0
PB Ratio: 5.42
GF Score: 55/100 
Roivant Sciences Ltd at TD Cowen Healthcare Conference Transcript
Mar 03, 2026 / 02:50PM GMT
Yaron Werber
Cowen and Company LLC - Analyst
All right, well, good morning, everybody, and thank you once again for joining us for the Forty-sixth Annual TD Cowen and Healthcare Conference. I'm Yaron Werber from the Biotech team, and it's a great pleasure to moderate the next fireside chat with Roivant, with the CEO. Really needs no introduction, Matt Gline. Good to see you. Really appreciate you being here.
Matthew Gline
Roivant Sciences Ltd - Chief Executive Officer, Director
Thanks for having me. I still don't think it's true that I need no introduction, but I appreciate it.
Yaron Werber
Cowen and Company LLC - Analyst
I think it's safe to say that everybody in this room and in the industry knows who you are,
Matthew Gline
Roivant Sciences Ltd - Chief Executive Officer, Director
So they came to the room.
Questions & Answers
Yaron Werber
Cowen and Company LLC - Analyst
So you announced today, [Kaya] and I
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers